Fund Holdings — Yiheng Capital Management, L.P.

Total Portfolio Value:
$709.14M
Total Bought:
$44.58M
Total Sold:
$89.20M
Net Transaction:
-$44.61M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Bilibili IncADS13,636,95112,669,249-967,702$152.73M$195.61M27.58%+$42.88M
JD.com, Inc.CL A(JD)3,204,3614,903,489+1,699,128$87.77M$126.71M17.87%+$38.94M
Noah Holdings LimitedADS(NOAH)6,719,7226,719,7220$76.81M$64.85M9.14%-$11.96M
H World Group LimitedADS(HTHT)1,975,4511,603,978-371,473$76.45M$53.44M7.54%-$23.01M
New Oriental Education & Technology Group Inc.ADR(EDU)707,629657,629-50,000$61.44M$51.12M7.21%-$10.32M
Roblox CorporationCL A(RBLX)1,220,7441,220,7440$46.61M$45.42M6.41%-$1.18M
Akero Therapeutics Inc1,434,1791,434,1790$36.23M$33.65M4.74%-$2.58M
TransDigm Group Incorporated(TDG)31,12126,021-5,100$38.33M$33.24M4.69%-$5.08M
Denali Therapeutics Inc.(DNLI)1,150,6841,150,6840$23.61M$26.72M3.77%+$3.11M
TAL Education GroupADS(TAL)1,935,7181,935,7180$21.97M$20.65M2.91%-$1.32M
Beam Therapeutics Inc.(BEAM)845,500845,5000$27.94M$19.81M2.79%-$8.13M
Viridian Therapeutics, Inc.(VRDN)948,130948,1300$16.60M$12.34M1.74%-$4.27M
ACM Research, Inc.CL A(ACMR)481,291446,104-35,187$14.02M$10.29M1.45%-$3.74M
Inventiva S.A.ADS(IVA)2,644,9262,644,9260$9.57M$7.91M1.12%-$1.67M
ATRenew Inc.ADS(RERE)163,4761,326,293+1,162,817$287.7K$3.14M0.44%+$2.86M
Dbv Technologies S AADR03,153,576+3,153,576$0$2.53M0.36%+$2.53M
Vistance Networks, Inc.(VISN)730,877730,8770$957.4K$899.0K0.13%-$58.5K
Generation Bio Co191,530191,5300$779.5K$540.1K0.08%-$239.4K
Tuniu CorporationADS(TOUR)0314,437+314,437$0$263.2K0.04%+$263.2K
Jianzhi Ed Technology GroupADR25,70225,7020$16.5K$14.9K0.00%-$1.5K
Dbv Technologies S AADR5,568,9090-5,568,909$4.17M$0—-$4.17M
Page 1 of 1
Yiheng Capital Management, L.P. — 13F Holdings — Q2 2024 | TickerTrail